Breaking News, Promotions & Moves

Lonza Group Welcomes New CEO

Wolfgang Wienand succeeds Albert M. Baehny, who took on the role of CEO ad interim in October 2023.

Wolfgang Wienand has joined Lonza Group as its new Chief Executive Officer (CEO), succeeding Albert M. Baehny, who took on the role of CEO ad interim in October 2023 and was Chairman of the Board of Directors of Lonza from 2018 to May 2024.

Baehny will work with Wienand to ensure a smooth leadership handover before he retires from Lonza this summer. Wienand’s appointment was announced earlier this year, in April.

About Wolfgang Wienand

Since 2019, Wienand has held the role of CEO at Swiss CDMO, Siegfried. He previously served as Chief Scientific Officer and then as Chief Strategy Officer in Siegfried’s executive leadership team. Prior to joining Siegfried in 2010, Wienand held a series of positions with increasing seniority at the German specialty chemicals company Evonik Industries.

Jean-Marc Huët, Chairman of the Board of Directors, Lonza, commented: “On behalf of the Board, I extend a warm welcome to Wolfgang as he joins Lonza. Wolfgang brings with him a wealth of CDMO experience, combined with deep strategic and scientific expertise. As Wolfgang joins, we look forward to an era of stable and structured growth under his leadership.”

Wienand remarked: “Having worked in the CDMO industry for almost two decades, I always had great respect for Lonza’s ability to transform and grow at pace. It is a privilege to join this remarkable company as CEO. As I commence my journey with Lonza, we are embarking on a quest to meet and exceed the needs of our customers and their patients. I am greatly looking forward to working with the team to build on our strong foundations and create a strategy for us to deliver continued growth and reach our full potential.”

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters